In this episode, Ben Scher talks to Dr Gabriela Khazanov, Professor James McKay and Professor Richard Rawson. They discuss what contingency management is and how effective it can be in treatment settings. They also talk about how contingency management can be used for stimulant use disorders; an area where there are relatively few evidence-based treatments.

the team goes on to discuss implementation of contingency management in the US and the barriers faced by practitioners such as predominant ethical concerns. They also cover how attitudes towards contingency management have changed over the past decade. The paper that was published in Addiction looked at ways to improve dissemination and implementation of contingency management.

Often patients are not able to re-engage in contingency management if they drop out or they’re not allowed to repeat contingency management. And all of that was done to prevent fraud and waste and those kinds of concerns. But we don’t limit other kinds of treatment. We don’t limit behavioural therapy, typically we don’t limit the ability to take medications that could potentially be effective.

Original article: Should contingency management protocols and dissemination practices be modified to accommodate rising stimulant use and harm reduction frameworks? by Gabriele Khazanov and colleagues. Published in Addiction (2024).

The opinions expressed in this podcast reflect the views of the host and interviewees and do not necessarily represent the opinions or official positions of the SSA or Addiction journal.

The SSA does not endorse or guarantee the accuracy of the information in external sources or links and accepts no responsibility or liability for any consequences arising from the use of such information.

---

Hosted on Acast. See acast.com/privacy for more information.